Key Dates

Related Announcements

RFA-NS-22-029 - Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to correct the Application and Submission Information for RFA-NS-22-029 "Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)". As stated in the Page Limits Section of Application and Submission Information, All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed. However, under the PHS 398 Research Plan, it states applicants must provide a 30 page Research Strategy. This information was erronesouly published in the Funding Opportunity Announcement (FOA). This notice removes this text and confirms the research stratgey page limit is 12 pages. Changes to the FOA are shown below.

Currently Reads:

Section IV. Application and Submission Information

PHS 398 Research Plan

Leading the network CCC will be a complex and time-consuming undertaking, and applicants must have the necessary experience and expertise to coordinate multi-center clinical trials in pediatric and adult patients with neurological disorders. Therefore, a listing of current and up to five of the most recently completed trials that the CCC applicant has coordinated must also be provided in the 30 page Research Strategy.

Modified To Read:

Section IV. Application and Submission Information

PHS 398 Research Plan

Leading the network CCC will be a complex and time-consuming undertaking, and applicants must have the necessary experience and expertise to coordinate multi-center clinical trials in pediatric and adult patients with neurological disorders. Therefore, a listing of current and up to five of the most recently completed trials that the CCC applicant has coordinated must also be provided in the 12 page Research Strategy.

All others aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Joan Ohayon, RN, MSN, CRNP, MSCN
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 3014969135
Email: ohayonj@ninds.nih.gov